최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기소아청소년정신의학 = Journal of the Korean Academy of Child and Adolescent Psychiatry, v.22 no.1, 2011년, pp.3 - 9
임명호 (단국대학교 환경보건센터) , 권호장 (단국대학교 환경보건센터)
Autism and autistic spectrum disorder are chronic neuro-developmental disorders characterized by social and language impairments and stereotyped, repetitive patterns of behavior. The etiology of autism remains unknown; however, a strong genetic component has been detected and environmental factors m...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
자폐 스펙트럼장애란 무엇인가? | 자폐장애 혹은 자폐 스펙트럼장애는 사회적 상호교류, 언어 및 의사소통, 그리고 반복적이고 상동적인 행동의 장애를 특징으로 하는 만성적인 신경발달 장애이다.1) 자폐 장애는 0. | |
자폐 장애 아동은 임상적으로 어떤 증상이 동반되는가? | 대체·보완치료의 한 예로 Casein 혹은 Glu-ten이 없는 우유 식이 요법이 있다. 임상적으로 자폐 장애 아동은 지속적인 복통, 설사, 변비, 구토 등의 장 기능 이상이 동반되고 있으며 이런 현상이 자폐 장애의 근본 병리 기전에 면역학적 혹은 환경적인 요인이 관여할 수 있다는 추론을 가능하게 한다. | |
James 등의 보고에 따르면, 자폐 장애에서 glutathione 합성, sulfation 결핍, folate 대사 등 여러 가지 대사과정의 결함을 갖는 원인은 무엇인가? | James 등47)은 자폐장애에서 낮은 농도의 methionine, S-adenosyl methionine(SAM), homo-cystein, cystathionine, cysteine, total glutathione과 높은 농도의 S-adenosyl homocysteine(SAH), adenosine, oxidized glutathione을 보고한 바 있다. 이러한 결과는 me-thylation의 손상(SAM, SAH)과 증가된 산화 스트레스에 의한 것으로 설명된다. Yorbik 등48)은 자폐장애에서 적혈구 su-peroxide dismutase와 적혈구 및 혈장 glutathione pe-roxidase의 활성이 낮아져 있음을 보고하였는데 이러한 결과는 혈액 내 항산화효소 체계의 이상과 연관되었을 수 있다. |
Bailey A, Phillips W, Rutter M. Autism: towards an integration of clinical, genetic, neuropsychological, and neurobiological perspectives. J Child Psychol Psychiatry 1996;37:89-126.
Fombonne E, Du Mazaubrun C, Cans C, Grandjean H. Autism and associated medical disorders in a French epidemiological survey. J Am Acad Child Adolesc Psychiatry 1997;36:1561-1569.
Bertrand J, Mars A, Boyle C, Bove F, Yeargin-Allsopp M, Decoufle P. Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation. Pediatrics 2001;108:1155-1161.
Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995;25:63-77.
Smalley SL, Asarnow RF, Spence MA. Autism and genetics: a decade of research. Arch Gen Psychiatry 1988;45:953-961.
Bristol MM, Cohen DJ, Costello EJ, Denckla M, Eckberg TJ, Kallen R, et al. State of the science in autism: report to the National Institutes Health. J Autism Dev Disord 1996;26:121-154.
Kolevzon A, Gross R, Reichenberg A. Prenatal and perinatal risk factors for autism: a review and integration of findings. Arch Pediatr Adolesc Med 2007;161:326-333.
Reichenberg A, Gross R, Weiser M, Bresnahan M, Silverman J, Harlap S, et al. Advancing paternal age and autism. Arch Gen Psychiatry 2006;63:1026-1032.
Lauritsen MB, Pedersen CB, Mortensen PB. Effects of familial risk factors and place of birth on the risk of autism: a nationwide register-based study. J Child Psychol Psychiatry 2005;46:963-971.
Croen LA, Grether JK, Hoogstrate J, Selvin S. The changing prevalence of autism in California. J Autism Dev Disord 2002;32:207-215.
Croen LA, Grether JK, Selvin S. Descriptive epidemiology of autism in a California population: who is at risk? J Autism Dev Disord 2002;32:217-224.
Eaton WW, Mortensen PB, Thomsen PH, Frydenberg M. Obstetric complications and risk for severe psychopathology in childhood. J Autism Dev Disord 2001;31:279-285.
Larsson HJ, Eaton WW, Madsen KM, Vestergaard M, Olesen AV, Agerbo E, et al. Risk factors for autism: perinatal factors, parental psychiatric history, and socioeconomic status. Am J Epidemiol 2005; 161:916-928.
Glasson EJ, Bower C, Petterson B, De Klerk N, Chaney G, Hallmayer JF. Perinatal factors and the development of autism: a population study. Arch Gen Psychiatry 2004;61:618-627.
Hultman CM, Sparen P, Cnattingius S. Perinatal risk factors for infantile autism. Epidemiology 2002;13:417-423.
Torrente F, Ashwood P, Day R, Machado N, Furlano RI, Anthony A, et al. Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol Psychiatry 2002;7:375-382.
Horvath K, Papadimitriou JC, Rabsztyn A, Drachenberg C, Tildon JT. Gastrointestinal abnormalities in children with autistic disorder. J Pediatr 1999;135:559-563.
Rosseneu S. Aerobic gut flora in children with autism spectrum disorder and gastrointestinal symptoms. Presented at: Deafeat Autism Now Conference. San Diego (CA), October 3, 2003.
Sandler RH, Finegold SM, Bolte ER, Buchanan CP, Maxwell AP, Vaisanen ML, et al. Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol 2000;15:429-435.
Weber W, Newmark S. Complementary and alternative medical therapies for attention-deficit/hyperactivity disorder and autism. Pediatr Clin North Am. 2007;54:983-1006.
D'Eufemia P, Celli M, Finocchiaro R, Pacifico L, Viozzi L, Zaccagnini M, et al. Abnormal intestinal permeability in children with autism. Acta Paediatr 1996;85:1076-1079.
Horvath K, Perman JA. Autism and gastrointestinal symptoms. Curr Gastroenterol Rep 2002;4:251-258.
Levy SE, Hyman SL. Complementary and alternative medicine treatments for children with autism spectrum disorders. Child Ado-lesc Psychiatr Clin N Am 2008;17:803-820.
Knivsberg AM, Reichelt KL, Høien T, Nødland M. A randomised, controlled study of dietary intervention in autistic syndromes. Nutr Neurosci 2002;5:251.
Elder JH, Shankar M, Shuster J, Theriaque D, Burns S, Sherrill L. The gluten-free, casein-free diet in autism: results of a preliminary double blind clinical trial. J Autism Dev Disord 2006;36:413.
Wolraich ML, Wilson DB, White JW. The effect of sugar on behavior or cognition in children. A meta-analysis. JAMA 1995;274: 1617-1621.
Lucarelli S, Frediani T, Zingoni AM, Ferruzzi F, Giardini O, Quintieri F, et al. Food allergy and infantile autism. Panminerva Med 1995;37:137-141.
Jyonouchi H, Sun S, Itokazu N. Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder. Neuropsychobiology 2002;46:76-84.
Connolly AM, Chez MG, Pestronk A, Arnold ST, Mehta S, Deuel RK. Serum autoantibodies to brain in Landau-Kleffner variant, au-tism, and other neurologic disorders. J Pediatr 1999;134:607-613.
Singh VK, Warren R, Averett R, Ghaziuddin M. Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr Neurol 1997;17:88-90.
Cabanlit M, Wills S, Goines P, Ashwood P, Van de Water J. Brain-specific autoantibodies in the plasma of subjects with autistic spec-trum disorder. Ann N Y Acad Sci 2007;1107:92-103.
Bernard S, Enayati A, Redwood L, Roger H, Binstock T. Autism: a novel form of mercury poisoning. Med Hypotheses 2001;56:462-471.
Ng DK, Chan CH, Soo MT, Lee RS.. Low-level chronic mercury exposure in children and adolescents: meta-analysis. Pediatr Int 2007; 49:80-87.
Palmer RF, Blanchard S, Stein Z, Mandell D, Miller C. Environmental mercury release, special education rates, and autism disorder: an ecological study of Texas. Health Place 2006;12:203-209.
DeStefano F. Vaccines and autism: evidence does not support a causal association. Clin Pharmacol Ther 2007;82:756.
Hviid A. Postlicensure epidemiology of childhood vaccination: the Danish experience. Expert Rev Vaccines 2006;5:641-649.
Myers SM, Johnson CP. Management of children with autism spectrum disorders. Pediatrics 2007;120:1162-1182.
Nye C, Brice A. Combined vitamin B6-magnesium treatment in autism spectrum disorder. Cochrane Database Syst Rev 2005:CD-003497.
Ip P, Wong V, Ho M, Lee J, Wong W. Mercury exposure in children with autistic spectrum disorder: case-control study. J Child Neurol 2004;19:431-434.
Adams JB, Romdalvik J, Ramanujam VM, Legator MS. Mercury, lead, and zinc in baby teeth of children with autism versus controls. J Toxicol Environ Health A 2007;70:1046-1051.
Bradstreet J, Geier D, Dkartzinel J. a case control study of mercury burden in children with autistic spectrum disorders. J American Physics Surgeons 2003;8:76-79.
Walsh W. Metallothionein and autism. Proceedings of the Defeat Autism now Conference; 2003 Oct 3; San Diego.
Sliwinski S, Croonenberghs J, Christophe A, Deboutte D, Maes M. Polyunsaturated fatty acids: do they have a role in the pathophysiology of autism? Neuro Endocrinol Lett 2006;27:465-471.
Vancassel S, Durand G, Barthelemy C, Lejeune B, Martineau J, Guilloteau D, et al. Plasma fatty acid levels in autistic children. Prostaglandins Leukot Essent Fatty Acids 2001;65:1-7.
Patrik L, Salik R. The effect of essential fatty acid supplementation on language development and learning skills in autism and Asperger's syndrome. Autism Asperger's Digest 2005;36-37.
Amminger GP, Berger GE, Schafer MR, Klier C, Friedrich MH, Feucht M. Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biol Psychiatry 2007;61:551-553.
James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 2004;80:1611-1617.
Yorbik O, Sayal A, Akay C, Akbiyik DI, Sohmen T. Investigation of antioxidant enzymes in children with autistic disorder. Prostaglandins Leukot Essent Fatty Acids 2002;67:341-343.
Kern JK, Jones AM. Evidence of toxicity, oxidative stress, and neuronal insult in autism. J Toxicol Environ Health B Crit Rev 2006;9:485.
Pardo CA, Eberhart CG. The neurobiology of autism. Brain Pathol 2007;17:434-437.
McGinnis WR. Oxidative stress in autism. Altern Ther Health Med 2004;10:22-36.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.